title: Graft-versus-host disease: have we solved the problem?
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008212:Lymphocyte Depletion / Q000379:methods*; D008297:Male; D011719:Pyrazines / Q000008:administration & dosage*; D035781:Siblings; D016176:T-Lymphocyte Subsets / Q000378:metabolism*
chemical_list: D018952:Antigens, CD34; D001897:Boronic Acids; D007166:Immunosuppressive Agents; D011719:Pyrazines; D000069286:Bortezomib